These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15751565)

  • 1. Treatment of deep vein thrombosis: what factors determine appropriate treatment?
    Douketis JD
    Can Fam Physician; 2005 Feb; 51(2):217-23. PubMed ID: 15751565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients.
    Schwarz T; Schmidt B; Beyer J; Schröder HE; Schellong SM
    J Vasc Surg; 2001 Dec; 34(6):1065-70. PubMed ID: 11743562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study.
    Zondag W; Mos IC; Creemers-Schild D; Hoogerbrugge AD; Dekkers OM; Dolsma J; Eijsvogel M; Faber LM; Hofstee HM; Hovens MM; Jonkers GJ; van Kralingen KW; Kruip MJ; Vlasveld T; de Vreede MJ; Huisman MV;
    J Thromb Haemost; 2011 Aug; 9(8):1500-7. PubMed ID: 21645235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk.
    Sandoval JA; Sheehan MP; Stonerock CE; Shafique S; Rescorla FJ; Dalsing MC
    J Vasc Surg; 2008 Apr; 47(4):837-43. PubMed ID: 18295440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry.
    Spirk D; Husmann M; Willenberg T; Banyai M; Frank U; Baldi T; Amann-Vesti B; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Feb; 105(2):239-44. PubMed ID: 20886197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
    Amin AN; Lin J; Thompson S; Wiederkehr D
    Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of deep vein thrombosis and pulmonary embolism in superficial thrombophlebitis of the lower limbs: prospective study of 60 cases.
    Sobreira ML; Maffei FH; Yoshida WB; Rollo HA; Lastória S; Griva BL; De Carvalho LR
    Int Angiol; 2009 Oct; 28(5):400-8. PubMed ID: 19935595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outpatient treatment of deep-vein thrombosis].
    Thyssen JP; Thielke D; Ørnstrup ML; Sejersen HM
    Ugeskr Laeger; 2007 Jan; 169(2):112-5. PubMed ID: 17227655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
    East AT; Wakefield TW
    Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs.
    Tzoran I; Saharov G; Brenner B; Delsart D; Román P; Visoná A; Jiménez D; Monreal M;
    J Thromb Haemost; 2012 Apr; 10(4):564-71. PubMed ID: 22288520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of deep vein thrombosis.
    Couturaud F; Kearon C
    Semin Vasc Med; 2001; 1(1):43-54. PubMed ID: 15199513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis.
    Kearon C
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():296-300. PubMed ID: 19630820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of deep-vein thrombosis.
    Scarvelis D; Wells PS
    CMAJ; 2006 Oct; 175(9):1087-92. PubMed ID: 17060659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants in the treatment of deep vein thrombosis.
    Merli G
    Am J Med; 2005 Aug; 118 Suppl 8A():13S-20S. PubMed ID: 16125510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.